Search results
TREMFYA® (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both...
Morningstar· 4 days ago"The Phase 3 GRAVITI...
I Have a Dry Cough, What Helps?
AOL· 3 days agoIt occurs as a natural reflex when inflammation or irritation affects your airway. A dry cough is also called a unproductive cough because it does not produce phlegm or mucus. There are many ...
The Koala Paradox
The Atlantic· 7 days agoFour months earlier, when Emerson was admitted to Northern Rivers Koala Hospital, in New South Wales, Australia, he was so small that volunteers had to...
Why Does Your Stomach "Growl"?
Mercola· 6 days agoYour body lets you know every day, in a variety of ways, that it is alive and well. One such way is the familiar growl of your stomach, which, to most of us, signals hunger. Is All That Noise ...
NYC air quality threat: Could Canadian wildfire smoke return in summer 2024?
FOX 5 New York· 2 days agoCould smoke from Canada wildfires once again impact NYC this year? FOX 5 NY's Liv Johnson has a look...
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be...
Digital Journal· 6 days agoBoth the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently ...
Heart Disease Is a Leading Killer of Women. Why Are Doctors So Bad at Diagnosing It?
PopSugar· 2 days agoIn May 2019, six months after a 35-year-old Marian Dancy gave birth to her second child, she became...
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be...
The Joplin Globe· 6 days agoIRVINE, CA / ACCESSWIRE / June 17, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...
5 Things a Patient Wants People to Know about NF1-PN
Wisconsin State Journal· 3 days agoDespite having gone through all of this, Antwan refuses to let NF1-PN impact his positive outlook and wants people to understand this rare disease,...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 3 days agoFood and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active Crohn's disease. The submission ...
